ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA20722-1mg |
|
186319-74-4 |
Amyloid β-Protein (1-14)
|
0 | C73H99N23O25 | |
GA20721-5mg |
|
142047-91-4 |
Amyloid β-Protein (1-12)
|
0 | C61H85N17O23 | |
GA20721-1mg |
|
142047-91-4 |
Amyloid β-Protein (1-12)
|
0 | C61H85N17O23 | |
GA20720-5mg |
|
237753-66-1 |
Amyloid β-Protein (10-35)
|
0 | C133H204N34O37S | |
GA20720-1mg |
|
237753-66-1 |
Amyloid β-Protein (10-35)
|
0 | C133H204N34O37S | |
GA20719-5mg |
|
1802086-24-3 |
Amyloid β/A4 Protein Precursor₇₇₀ (740-770)
|
0 | C162H243N45O52S2 | |
GA20719-1mg |
|
1802086-24-3 |
Amyloid β/A4 Protein Precursor₇₇₀ (740-770)
|
0 | C162H243N45O52S2 | |
GA20718-5mg |
|
252256-37-4 |
Amyloid β/A4 Protein Precursor₇₇₀ (667-676)
|
0 | C51H82N14O18S | |
GA20718-1mg |
|
252256-37-4 |
Amyloid β/A4 Protein Precursor₇₇₀ (667-676)
|
0 | C51H82N14O18S | |
GA20717-1mg |
|
189125-14-2 |
Amyloid Precursor Frameshift Mutant C-Terminal Peptide
|
0 | C44H81N17O16 | |
GA20717-005mg |
|
189125-14-2 |
Amyloid Precursor Frameshift Mutant C-Terminal Peptide
|
0 | C44H81N17O16 | |
GA20716-5mg |
|
180387-75-1 |
Amyloid P Component (27-38) amide
|
0 | C68H107N19O17S | |
GA20716-1mg |
|
180387-75-1 |
Amyloid P Component (27-38) amide
|
0 | C68H107N19O17S | |
GA20715-1mg |
|
1802083-00-6 |
Amyloid Dan Protein (1-34) (reduced)
|
0 | C185H270N48O51S2 | |
GA20715-005mg |
|
1802083-00-6 |
Amyloid Dan Protein (1-34) (reduced)
|
0 | C185H270N48O51S2 | |
GA20714-5mg |
|
1802078-21-2 |
Amyloid Bri Protein Precursor₂₇₇ (89-106)
|
0 | C87H141N21O30S | |
GA20714-1mg |
|
1802078-21-2 |
Amyloid Bri Protein Precursor₂₇₇ (89-106)
|
0 | C87H141N21O30S | |
GA20713-1mg |
|
1802081-65-7 |
Amyloid Bri Protein (1-34)
|
0 | C173H273N49O52S2 | |
GA20713-005mg |
|
1802081-65-7 |
Amyloid Bri Protein (1-34)
|
0 | C173H273N49O52S2 | |
GA20712-1mg |
|
321853-88-7 |
Amyloid Bri Protein (1-34) (reduced)
|
0 | C173H275N49O52S2 | |